Synthesis of (E) -N'-(5-bromo 2-hydroxybenzylidene)nicotinohydrazide) and its Pt(II), Zn(II), Mn(II), Ni(II) and Mo(V) Complexes as potential Anti-tubercular agent by Adekoya, J. A.
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cell wall, which resisted many antibiotics and also hinders 
the entry of drugs (Jia et al., 2005). The standard DOTS 
course (Directly Observed Treatment Short course) for 
TB is a 6 months treatment (Jindani et al., 2004). Most of 
the current drugs for the treatment of TB resulted from the 
research performed over half a century ago (Sacchettini et 
al., 2008). Hence, there is an urgent need to develop more 
potent and fast acting anti-TB drugs with new modes of 
action to overcome the cross-resistance with current drugs 
and with low toxicity profiles that can be tolerated for 
long treatment periods (Salib et al., 2003). Presently, 
some drugs are under clinical trial by several public and 
private partnerships (Dover and Coxon, 2011). Despite 
the severe outbreak of TB and the rise of MDR strains, 
progress to find a new vaccine or improvement of the 
BCG vaccine has been very slow. Several numbers of 
approaches such as target-based drug design, 
combinatorial synthesis, high-throughput screening, etc., 
have been explored to generate new novel compounds. 
However, chemical modification of a known anti-TB drug 
has been reported to be a successful approach in the 
development of new anti-TB agent (Ramon-Garcia et al., 
2011). The present study is focus on the synthesis and 
characterization of the hydrazone obtained in the 
condensation reaction of nicotinic hydrazide with 5-
bromosalicaldehyde and its Pt(II), Zn(II), Mn(II), Ni(II) 
and Mo(V) complexes. The structure of the ligand was 
established with the use of some spectroscopy study while 
the structures of the metal complexes were proposed. The 
in vitro anti-tubercular activity against resistant strains of 
H37Rv was carried out to determine the anti-tubercular 
potential of the compounds.  
 
MATERIALS AND METHODS 
 
Nicotinic hydrazide, 5-bromosalicylaldehyde, PtCl2, 
Zn(COOCH3)2, Mn(COOCH3)2.4H2O, NiCl2.4H2O, 
MoCl5 and solvents with high purity were purchased from 
Sigma-Aldrich. They are of high purity and were used as 
purchased.  
 
The melting points of all the compounds were determined 
by using Gallenkamp melting point apparatus (Davidson, 
2010). The % of carbon, nitrogen and hydrogen in the 
synthesized hydrazones and metal complexes were 
determined by using Vario EL CHNS analyser at 
Sophisticated Analytical Instruments Facilities at Central 
Drug Research Institute, Lucknow, India. ESI-MS 
spectrum for the hydrazone was collected from Agilent 
6520 Q-TOF mass spectrometer and MeOH solution was 
used as the solvent. Mass spectra were measured in 
positive mode and in the range m/z = 200-1400. The 
percentage of metal in the synthesized metal complexes 
was determined by using Varian spectrometer AAS-110. 
The molar conductivities of the metal complexes at 
ambient temperature in DMF solution (10-3M) were 
measured using systronics – 304 conductivity meter .The 
electronic data of the hydrazone and the metal complexes 
were obtained in methanol/DMSO by using Perkin Elmer 
Spectro UV-visible Double Beam UVD spectrometer in 
the range of 200-700 nm. The infrared spectra for the 
hydrazone and the metal complexes were recorded on 
Perkin – Elmer RX-1 Fourier Transform Infrared 
Spectrometer using KBr pellets in the range of 400-400 
cm-1. 1H NMR, 13C NMR and 2D NMR (COSY and 
HSQC) spectra of the hydrazone were recorded by using 
Bruker AMX 300 FT-NMR spectrometer in DMSO-d6. 
The magnetic susceptibility data of the paramagnetic 
metal complexes were measured at room temperature by 
using vibrating susceptibility magnometer (PAR 155) 
with magnetic field of -10 to +10 kOe at instrumentation 
center, Indian Institute of Technology, Roorkee, India.  
TGA/DTA analyses of the metal complexes were carried 
out, at heating rate of 10 oC min-1, under inert atmosphere 
by using thermogravimetric analyser TGA Q500 V20.8 
Build 34 model. The EPR spectra of the metal complexes 
at 77 K were recorded on a Varian E-112 spectrometer 
using TCNE as the standard, with 100 KHz modulation 
frequency, modulation amplitude 2G and 9.1 GHz 
microwave frequency. X-ray powder diffraction pattern 
for Ni(II) complex was recorded on a Bruker AXS D8 
Advance diffractometer operating in the θ:θ mode and 
equipped with a secondary beam graphite mono-
chromator.  
 
Synthesis of the hydrazone  
The synthetic methods described earlier (Nair, 2012; 
Abeda, 2012) were modified and adopted. The nicotinic 
acid hydrazide (10 mmol, 342 mg) was dissolved in 20 ml 
absolute ethanol by heating gently on water bath. The 
solution of nicotinic acid hydrazide was mixed with 20 ml 
ethanolic solutions of 5-bromosalicaldehyde (10 mmol, 
503 mg) in a round bottom flask after which the mixture 
was stirred at 20oC for 6 h (Scheme 1). The precipitates 
obtained were allowed to stay at room temperature for 12 
h before they were filtered, and washed with 30 ml of 
ethanol thrice. The compound obtained was recrystallized 
in mixture of dried chloroform. Vacuum pump rotary 
evaporator was used to ensure complete dryness. The 
purity was checked by TLC (10% methanol: 90% 
chloroform).  
 
Yield 2.52 g (78%); milky colour solid; mp: 220-222oC; 
Rf = 0.82 (CHCl3 / CH3OH, 4:1, at RT.). IR (KBr) cm-1: 
3418 (ArOH), 3266 (NH), 1675 (C=O), 1610 (C=N), 
1529 (N-N), 1339 (C-O), 1147(C-N). MS (ESI+): in m/z: 
320.0 [M+ H]+. Anal. calcd. for C13H10 BrN3O2 (319.00): 
C, 48.90; H, 3.13; N, 13.16. Found: C, 48.76; H, 3.47; N, 
12.78. 1H-NMR (DMSO-d6) δ: 12.32(s, 1H, NH), 11.19 
(s, Ar-OH, 1H), 9.08 (d, J1 = 1.2 Hz, 1H, H(3)), 8.78 (dd, 
J1 = 4.8 Hz, J2 = 7.9 Hz, 1H, H(4)), 8.61 (s, 1H, H-C=N), 
8.29 ( dt, J1 = 1.5 Hz, J2 = 8.1 Hz ,1H, H(6)), 7.81 (d, J = 
2.4 Hz, 1H, H(7), 7.59 ( m, J1  = 4.8 Hz, J2  = 8.1 Hz, 1H, 
H(8), 7.44 (dd, J1 = 2.4 Hz, J2 = 8.7 Hz, 1H, H(9) , 6.92 
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(d, J = 8.7 Hz, 1H, H(10), ppm. 13C-NMR (DMSO-d6) δ: 
162.56 (CO), 156.40 (C-OH),  152.41 (C3),  148.60 (C4), 
146.03 (HC=N), 135.45 (C6), 133.71 (C7), 130.26 (C8), 
128.53 (C9), 123.57 (C10), 121.19  (C11), 118.63 (C12), 
110.47 (C13), ppm. 
 
Synthesis of the metal complexes 
[Mn(H2L3)(CH3COO)2]: To an ethanolic solution of 
H2L3 (10 mmole, 161 mg), 10 mmole (153 mg) of 
[Mn(CH3COO)2.4H2O] dissolved in 20 ml of ethanol was 
added slowly after which 2 drops of TEA was added. The 
mixture was refluxed at 80oC for 4 h. The brown product 
formed was filtered, washed with ethanol followed by 
ether and dried over P4O10 in vacuo. Elemental Anal. 
found (Calcd.) (%): Mn, 10.73 (11.14); C, 41.16 (41.40); 
H, 2.84 (3.27); N, 9.23 (8.52).  µ= 5.54 BM. 
 
[Zn(H2L3)(CH3COO)2H2O]: 229 mg (10 mmole) of 
Zn(CH3COO)2 was dissolved in 10 ml of mixture of 
ethanol and distilled water (1:1). The solution obtained 
was added gradually to 400 mg ethanolic solution of H2L3 
(10 mmole in 10 ml of absolute ethanol) in a round 
bottom flask after which two drops of TEA was added. 
The solution was refluxed at 80oC for 4 h. The yellow 
precipitate formed was allowed to cool to ambient 
temperature after which it was filtered, washed with 15 ml 
of ethanol and then with 10 ml of ether. The precipitate 
obtained was dried by using vacuum rotary evaporator. 
Elemental Anal. found (Calcd.) (%): Zn, 13.01 (12.54); C, 
39.25 (39.14); H, 3.37 (3.48); N, 8.23 (8.06). µ= 0 BM. 
 
[Pt(H2L3)Cl]: 166 mg (10 mmole) of PtCl2 dissolved in 
10 ml of absolute ethanol was added to 400 mg (10 
mmole) of H2L3 dissolved in 10 ml of absolute ethanol. 
The mixture was refluxed at 80 oC for 5 h after which it 
was left at room temperature for 24 h during which green 
precipitates formed. The precipitate formed was filtered, 
washed with cold ethanol and then dried over P4O10 in 
vacuo. Yield: 0.189 g (54.93 %). Elemental Anal. found 
(Calcd.) (%): M, 34.78 (35.43); C, 27.65 (28.35); H, 2.15 
(1.83); N, 7.96 (7.63). µ= 0 BM. 
 
[Ni(H2L3)(Cl)2]H2O: 149 mg (10 mmole) of NiCl2.4H2O 
dissolved in 10 ml of absolute ethanol was added to 20 ml 
ethanolic solution of H2L3 (800 mg, 20 mmole) in a round 
bottom flask after which two drops of TEA was added. 
The solution was refluxed at 80 oC for 6 h. The precipitate 
formed was filtered, washed with 20 ml of ethanol and 
then with 10 ml of ether. The precipitate obtained was 
dried over P4O10 in vacuo. Elemental Anal. found (Calcd.) 
(%): Ni, 13.23 (12.55); C, 32.69 (33.38); H, 2.12 (2.59); 
N, 8.59 (8.98). µ= 3.53 BM. 
 
Scheme 1. Synthetic pathway for H2L3 and its metal complexes.
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[Mo(H2L3)2(Cl)3]: Equivalent of 10 mmole (171 mg) of 
MoCl5 was weighed into appendorf in a fumes cupboard 
and transferred directly into the 10 ml of absolute ethanol 
in a double neck round bottom flask. The appendorf was 
rinsed into the solution with 5 ml of ethanol. Then 
solution of (400 mg, 10 mmole) of H2L3 in 15 ml of 
absolute ethanol was added. The mixture was refluxed at 
80oC for 5 h under nitrogen gas. The solute obtained was 
filtered, washed with cold ethanol and dried over P4O10 in 
vacuo. Yield: 0.187 g (57.36%). Elemental Anal found 
(Calcd.) (%): Mo, 17.95 (18.36); C, 30.36 (29.89); H, 
2.43 (1.93); N, 7.97 (8.04). µ= not determined BM. 
 
Antimycobacterial Activity Study 
MIC determination  
The synthesized hydrazone and metal complexes were 
evaluated for in vitro anti-mycobacterial activity. The 
compounds were screened against M. tuberculosis H37Rv 
in triplicate using broth dilution method (Anna, 2009; 
Gopalakrishnan, 2008). The compounds were screened 
against isoniazid (ATCC 35822) resistant strains of M. 
tuberculosis. The compounds were serially diluted from 
concentration of 500 µg/mL to 25 µg/mL in DMSO. M. 
tuberculosis H37Rv strain was used in Middle brook 7H-
9 broth which was inoculated with standard as well test 
compounds and incubated at 37°C for 4 weeks. The 
bottles were inspected for growth trice a week for a period 
of three weeks. Readings were taken at the end of 4 
weeks. The appearance of turbidity was considered as 
growth and indicates resistance to the compound. The 
growth was confirmed by making a smear from each 
bottle and performing a ZN stain.  
 
RESULTS AND DISCUSSION 
 
The reaction of nicotinic acid hydrazide with 5-
bromosalicylaldehyde (see Scheme 1) gave the desired 
dissymmetric tridentate Schiff base hydrazone in high 
 
 
 
 
 
 
 
 
 
Fig. 1. 1H NMR spectrum of H2L3 in DMSO-d6 at 300 MHz. 
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yield and purity. The ESI mass spectrum (Supplementary 
1) for the compound confirmed the molecular mass of the 
compound with molecular ion peak (M + 1) at 320.2. The 
molecular ions peak observed was supported by micro 
analysis data obtained.  
 
1H NMR spectrum study  
The 1H NMR spectrum of the compound in DMSO-d6 
(Fig. 1) displayed singlet peak which was assigned to an 
immine proton, H(1) in the hydrazone at 12.32 ppm. It 
resonated down the field due to highly desheilding effect 
from N(2) atom. This assignment was confirmed by 
deuterium exchange in which the intensity of this band 
decreased considerably (Devidas et al., 2011; Parekh et 
al., 2005). The singlet peak at 11.19 ppm corresponded to 
hydroxyl proton H(2), which was highly de-shielded by 
attached oxygen atom. In the pyridyl ring, the two 
adjacent protons, H(3) and H(4), to nitrogen atom N(1) 
appeared downfield at 9.08 and 8.78 ppm. However, the 
peak at 9.08 ppm is a doublet peak while the peak at 8.78 
ppm appeared as doublet of doublet. The two peaks 
experienced hydrogen bonding from neighboring nitrogen 
atom and thus resonated downfield. The multiplet peak at 
7.59 ppm which integrated as one proton, was assigned to 
H(8) protons. The doublet of triplet peak at 8.29 ppm was 
assigned to H(6) proton. The singlet peak which 
integrated as one proton at 8.61 ppm was assigned to H(5) 
proton in the hydrazone.  The proton experienced high 
reduction in the electron density around it from the 
adjacent nitrogen atom N(3). The two peaks observed at 
7.81 and 7.44 ppm were assigned to H(7) and H(9) 
protons respectively. High δ values for the two protons 
are based on their ortho position to bromine atom in the 
phenol ring.  H(10) proton in the phenol ring was 
assigned to a doublet peak that resonated at 6.92 ppm. 
 
 
13C NMR spectrum study  
13C NMR spectrum (Fig. 2) confirmed thirteen carbon 
atoms in the hydrazone ranging from 110.47 to 161.56 
ppm as envisaged. The carbonyl carbon C(1) appeared 
downfield at 161.56 ppm due to its direct attachment to 
oxygen that reduced its electron density. The observation 
was coupled with conjugative effect from N(2)-N(3) core 
in the hydrazone. The peak at 156.40 ppm was assigned to 
the carbon C(2) attached to hydroxyl group in the 
molecule. The downfield position is partially due to inter-
hydrogen bonding experienced by the OH group (Pavia et 
al., 2008).  In the pyridyl ring, the two carbon atoms 
adjacent to N(1), C(3) and C(4),  resonate at lower field of 
δ 152.41 ppm and 148.60 ppm, respectively. The other 
carbon atoms in the pyridyl ring are C(6), C(8) and C(10). 
They were assigned to the peak at 135.45, 130.26 and 
123.57 ppm respectively. The resonances assigned to the 
 
 
 
 
 
Fig. 2. 13C NMR spectrum of H2L3 in DMSO-d6 at 75 MHz. 
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carbon atoms in the phenol ring are C(7) 133.71; C(9) 
128.53; C(11), 121.19; C(12) 118.63 and C(13) 110.47 
ppm. The carbon atom attached to Br atom, C(9), 
appeared at much lower field than other carbon because it 
experienced much reduction in its electron density than 
the other carbons. However, C(5) atom was assigned to 
the peak that resonated downfield at 146.03 ppm. The 
peak appeared at the lower field due to high de-shielding 
effect from adjacent N(3)- N(2) core of the hydrazone. 
 
COSY spectrum study 
1H-1H correlation spectroscopy confirmed the 
assignments of proton NMR spectrum. There was no 
correlation for the peaks at 12.32, 11.19 and 8.61 ppm, 
which confirmed the absence of coupling interaction for 
each of these protons with their neighboring protons in 
the molecule. However, off diagonal contours were 
observed in the pyridyl ring and phenol ring region. The 
proton atom at 7.59 ppm, assigned to H(8), experienced 
coupling effect from both H(6)  at 8.29 ppm and H(4) at 
8.78 ppm.  Also, the peak at H(6) correlated with the peak 
at 9.08 ppm, H(3)  and this account for the doublet of 
triplet peak at 8.39 ppm  assigned to H(6). The peak at 
7.59 ppm appeared as multiplet due to two ortho coupling 
experienced while the peak at 8.78 ppm appeared as 
doublet of doublet peak. In the phenol ring region, the 
proton at 7.44 ppm which was assigned to H(9) proton 
correlate with both H(7) proton at 7.81 ppm and H(10) at 
6.92 ppm. Therefore, this justified doublet of doublet 
peak observed at 7.44 ppm while both H(7) and H(10) 
 
(a) (b) 
 
Fig. 3. COSY spectrum and schematic structure for H2L3 recorded in DMSOd6 at 300 MHz. 
 
 
(a) (b) 
 
Fig. 4. HSQC spectrum and schematic diagram for H2L3 recorded in DMSO-d6 at 75 MHz. 
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protons resonated as doublet peaks. Based on this, 1H-1H 
coupling for the hydrazone is shown in figure 3b. 
 
HSQC spectrum study 
The 1H-13C HSQC correlation spectrum which was 
recorded in DMSO-d6 ascertained both 1H and 13C NMR 
assignments. The 1H-13C HSQC connectivity in this 
spectrum is in agreement with both 1H and 13C spectral 
assignments. From the HSQC spectrum (Fig. 4), the peaks 
at 161.56, 156.40, 130.26, 121.19 and 110.47 ppm 
assigned to C(1), C(2), C(8), C(11) and C(13) 
respectively did not show correlation with any of the 
proton in the hydrazone. This confirmed that they are 
non-protonated carbons. However, HSQC spectrum 
showed 8 protonated carbons as expected for the 
molecule. All the correlation observed matched the 1H 
and 13C NMR assignments. Based on the spectrum, the H-
C correlation scheme is shown in figure 4. 
 
Analytical data of the metal complexes 
The synthesized metal complexes of H2L3 possess 
characteristics colour with high melting point (>300oC) 
due to the coordination bonds (Table 1). They were found 
to be sparingly soluble in methanol, DMF and THF but 
were soluble in DMSO and pyridine. The results of 
elemental analyses (C, H, N) obtained are in good 
agreement with the calculated values. The magnetic 
susceptibility values recorded at room temperature for 
Mn(II) and Ni(II) complexes compete favorably with the 
calculated spin only magnetic values. The conductivity 
values of the metal complexes are very low, thus 
suggesting non-electrolytic character of the metal 
complexes. 
 
Infra-red spectra studies  
The infrared spectral assignments of H2L3 compared to its 
metal complexes are presented in table 2. The comparison 
of the infrared spectrum of H2L3 with the spectra of the 
metal complexes, figure 5, showed significant variation in 
the chromophoric absorption bands due to the effect of 
coordination. The broad band around 3418 cm-1 which 
was assigned to ν(OH) stretching modes in H2L3 was 
observed in the spectra of Zn(II), Pt(II) and Mo(V) 
complexes at higher wavenumbers (3419-3456 cm-1), 
coupled with increased broadness. This observation was 
attributed to the effect of coordination of the oxygen atom 
of the OH group after deprotonation (Kuriakose et al., 
2007). Also, Ni(II) and Mn(II) complexes showed ν(M-O) 
absorption band at lower wavenumbers with reduction in 
its intensity due to presence of intra-molecular hydrogen 
bond in the two complexes.  
 
The strong band at 1675 cm-1 attributed to ν(C=O) 
vibrational stretching mode in H2L3 appeared in the 
spectra of the metal complexes at lower wavenumber 
from 1606 cm-1 in Mn(II) complex to 1655 cm-1 in Pt(II) 
complex. The intensities of the peaks were observed to 
have reduced as a result of coordination which reduced 
the vibrational force of CO group upon coordination. This 
is further supported by variation in the positions of δ(C-
O) deformation peaks in the complexes. The δ(C-O) 
deformation peak in the ligand appeared as a medium 
peak at 1339 cm-1. The peak appeared as a weak peak at 
higher frequencies in Pt(II), Ni(II) and Mo(V) complexes. 
However, it appeared as a medium peak with lower 
frequencies in Mn(II) and Zn(II) complexes. 
 
The azomethine group ν(C=N) band which appeared as a 
medium peak at 1610 cm-1 in the spectrum of the ligand 
appeared at lower wavenumber in Mn(II), Zn(II) and 
Mo(V) complexes but at a slightly higher wavenumber in 
Pt(II) and Ni(II) complexes. However, δ(C-N) 
deformation mode for all the complexes was affected by 
coordination effect by shifting to higher wavenumber 
when compared to that of the ligand due to the 
coordination. The amide NH vibational stretching mode 
appeared as a medium peak at 3266 cm-1 in the spectrum 
of the hydrazone but could not be found in the metal 
complexes due to conjugation effect of the coordination 
of azomethine group to the central metal ions in the 
complexes.  
 
Table 1. Analytical data of H2L3 metal complexes. 
Complex  Colour  M. pt.
oC 
Found (Calc.), % ΛM 
S cm2 
mol‐1 
μeff
μB M C H N 
[Mn(H2L
3)(CH3COO)2] (2)  Yellow  300 10.73
(11.14) 
41.16
(41.40) 
2.84
(3.27) 
9.23 
(8.52) 
35  5.54
(5.92) 
[Zn(H2L
2)(CH3COO)2H2O]   (3)  Yellow  300 13.01
(12.54) 
39.25
(39.14) 
3.37
(3.48) 
8.23 
(8.06) 
48  ‐
 
[Pt(H2L
3)Cl]    (4)  green  300 34.78
(35.43) 
(27.65
(28.35) 
2.15
(1.83) 
7.96 
(7.63) 
28  ‐
 
[Ni(H2L
3)Cl2]H2O  (5)  Golden 
yellow 
300 13.23
(12.55) 
32.69
(33.38) 
2.12
(2.59) 
8.59 
(8.98) 
43  3.53
(2.83) 
[Mo(H2L
3)Cl3]   (6) 
 
Black  300 17.95
(18.36) 
30.35
(29.89) 
2.43
(1.93) 
7.97 
(8.04) 
38  ‐
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The assignment of the proposed coordination sites is 
further supported by the appearance of new bands 
between 554-668 cm-1 and 418-523 cm-1. They were 
assigned to M-N and M-O bands, respectively. 
                              
Electronic Spectra Study  
The electronic spectral assignments of the metal 
complexes in methanol are presented in table 3. The 
interpretation was done on the basis of comparison of the 
spectrum of the ligand with the spectral of the metal 
complexes.  In a d5 high spin Mn(II) complex , spin 
allowed d-d transition is not expected due to the fact that 
such transition are Laporte and spin forbidden (Mangalam 
et al., 2009). Thus, for Mn(II) complex, the intensities of 
transition from ground state to the state of four–fold 
multiplicity are very weak as compared the ligand. 
However, the spectrum of the complex showed three 
significant intra-ligand transitions at ca. 43478, 36364 and 
 
 
 
Fig. 5. Infrared spectra for H2L3, Mn(II) and Pt(II) complex respectively. 
 
Table 2. Infrared data of metal complexes of H2L3. 
Ligands/Complex  ν(OH) 
cm‐1 
ν(C=O)
cm‐1 
ν(C=N)
cm‐1 
ν(N‐N)
cm‐1 
δ(C‐O)
cm‐1 
δ(C‐N) 
 cm‐1 
(M‐N)
 cm‐1 
(M‐O)
cm‐1 
H2L
3 (1)  3418 s  1675vs 1610 m 1529 m 1339 m 1147 m  ‐  ‐
[Mn(H2L
3)(CH3COO)2] (2)  3411 m,b  1604w 1561 w 1467 m 1311 m 1153 m  631 w  520 w
[Zn(H2L
2)(CH3COO)2H2O] (3)  3428 s,b  1611 m 1539 w 1427 w 1269m 1187 m  662 w  429 w
[Pt(H2L
3)Cl2]    (4)  3456 s,b  1655 w 1611 w 1470 m 1347 w 1184 m  625 w  455 w
[Ni(H2L
2)Cl2]H2O  (5)  3402 s,b  1651m 1610 w 1566 m 1349 w 1184 m  554 w  477 w
[Mo(H2L
3)Cl3]    (6)  3419 s,b  1630 s 1538 w 1461 w 1346 w 1187 w  668 w  418 w
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32680 cm-1. They were assigned to π→π* of aromatic 
ring system, n→π* of azomethine group and n→π* of 
carbonyl group respectively. The complex showed a high 
intense transition at visible region due to ligand to metal 
charge transfer (LCMT) transition. It was assigned to 2A1 
← 2B2 transition. This observation is of the characteristic 
of the tetrahedral pyramidal geometry. Zn(II) ion is of d10 
configuration, therefore, d-d transitions are not expected 
in the complexes. The intra-ligand transitions appeared in 
the complexes at higher wavelength with low intensities 
due to coordination effect on the chromophoric group. 
However, a very weak shoulder peak, which is attributed 
to metal- ligand charge transfer, is observed at ca. 17182 
cm-1 perharps, because of the yellow colour of the 
complex (Mohareb et al., 2011). Pt(II) is of d9 
configuration with term symbol 3D. Therefore, only one 
d-d transition is expected. However, the spectrum of the 
complex showed only three significant transitions at ca. 
45662, 34483 and 29240 cm-1 in the region studied. They 
were attributed to intra- ligand transitions. The transitions 
experienced slight shift due to coordination effect.  
 
Ni(II) complex spectrum showed three bands attributed to 
intra-ligand transitions at ca. 45871, 34602 and 29325  
cm-1. However, absence of peak below 16000 cm-1 ruled 
out the possibility of tetrahedral geometry. The magnetic 
value, 3.53 BM, obtained supported distorted octahedral 
geometry. The low intense peak at ca. 23981 cm-1 in the 
visible region of the spectrum is attributed to ligand-metal 
charge transfer (LCMT) in the complex.  
 
Mo(V) is of d5 confuguration with term symbol 7S, The 
spectrum of the complex consists of weak spin-forbidden 
bands at ca. 24691 and 16077 cm-1. The d-d transition 
from this high spin d5 configuration complex is possible 
due to pairing of some electron parallel spins in the 
complex. Using the Orgel diagram, the bands were 
assigned to transitions 5T1g ← 7A1g and 5T2g(G) ← 7A1g 
transition. However, the two bands at ca. 43290 and 
32258 cm-1 were assigned to intra-ligand bands. The band 
at ca. 46512 cm-1 in the spectrum of the ligand could not 
be traced to metal complex, thus suggesting distorted 
geometry for the complex. 
 
 
TGA/DTA Analyse  
TGA and DTA curves obtained for Mn(II) and Ni(II) and 
complexes within the temperature range from ambient 
temperature up to 700oC in an inert atmosphere are as 
shown in Fig. 6.  The curve for Mn(II) complex shows 
that the compound was very stable from ambient 
temperature up to 339oC. However, the compound 
decomposed in two steps at 348 and 427oC as shown in 
the DTG peaks. The H2L3 ligand constitute 60% of the 
complex but only 50% weight loss was observed  in the 
first decomposition step between 339-417 oC. The second 
decomposition step which occurred between 417-440 oC 
Table 3. Electronic data of H2L3 and its metal complexes. 
Compound  Transition 
cm‐1 
Ground Term 
Symbol 
Transition
H2L
3(1)  46512 
34722 
29326 
‐ π→π* (C=C) ar.
n→π* (C=N) 
n→π* (C=O) 
[Mn(H2L
3)(CH3COO)2]  (2)  43478 
36364 
32680 
23095 
6S
 
π→π* (C=C) ar.
n→π* (C=N) 
n→π* (C=O) 
6A1 ← 
6B2 
[Zn(H2L
3)(CH3COO)2H2O]      
(3) 
45454 
33557 
25974 
17182 
5D π→π* (C=C) ar.
n→π* (C=N) 
n→π* (C=O) 
MLCT 
[Pt(H2L
3)2.Cl]  (4)  45662 
34483 
29240 
3D
 
π→π* (C=C) ar.
n→π* (C=N) 
n→π* (C=O) 
[Ni(H2L
3)2)Cl2]H2O  (5)  45871 
34602 
29325 
23981 
3F
 
π→π* (C=C) ar.
n→π* (C=N) 
n→π* (C=O) 
MLCT 
[Mo(H2L
3)2.Cl3] (6)  43290 
32258 
24691 
16077 
7S n→π* (C=N)
n→π* (C=O) 
5T1g ← 
7A1g  
5T2g(G) ← 
7A1g  
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corresponds to 10% (Cald. 9.9%) weight loss. This was 
attributed to decomposition of CH3CO from the 
coordinated CH3COO group. The residue at 440oC 
contained 10% of the H2L3 ligand. Thus, the complex did 
not fully decompose at the temperature range studied.  
Nevertheless, the thermogram was useful in predicting the 
structure of the complex (Munde et al., 2012; Artur et al., 
2013). The TG and DTG curves for Ni(II) complex 
proceeded with five degradation steps which occurred at 
82, 197, 288, 341 and 456oC. The first step decomposition 
occurred with the loss of lattice water outside the 
coordination sphere at the temperature range of 80-92oC 
and this corresponded to 4% weight loss. The second and 
the fourth decomposition steps occurred within the 
temperature range of 173-205 and 332-352oC and 
accounted for 8% loss each which is attributed to the loss 
 
(a) 
 
(b) 
Fig. 6. TGA/ DTA spectrum for Mn(II) and Ni(II) complex respectively. 
 
Ogunniran et al. 3529
of coordinated chlorine atoms in the complex.  The 
decompositions which occurred within 262-302oC and 
352-460oC were attributed to decomposition of H2L3 
ligand. The decompositions accounted for 17% and 39% 
weight loss respectively. Thereafter, the compound 
decomposed to residue which is about 24% of the 
compound.  
 
 
Electron Paramagnetic Resonance Spectra 
The EPR spectra for Mn(II) and Mo(V) complexes 
recorded in DMSO at liquid nitrogen temperature are as 
shown in figure 7. Electron paramagnetic resonance 
spectrum of [Mn(H2L3)2(CH3COO)2] displayed one broad 
spectrum with no hyperfine splitting, which could be as a 
result of large D value  i.e the axial zero field splitting  for 
the complex as  indicated in the spin Hamiltonian for  
manganese(lI). 
Ĥ = gβHs + D{Sz2 – 1/3S(S+1)} + E (Sx2 – Sy2)  
However, the observed gav = 2.0361 value was found to be 
very close to the free electron spin value, 20023 which is 
consistent with the typical manganese (II) and also 
suggestive of the absence of spin orbital coupling in the 
ground state 6A1. The other g values are g|| = 3.7080 and 
g⊥ = 1.9842. The fact that g|| > g⊥ favoured octahedral 
geometry for the complex but the magnetic values 
obtained proposed distorted geometry which is an 
indication that one corner of the complex was occupied 
by lone pair of electron.  
 
The X-band EPR spectrum of [Mo(H2L3)Cl3] is 
characterized by only a single line with no hyperfine 
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Fig. 7. EPR spectrum for [Mn(H2L3)2(CH3COO)2] and [Mo(H2L3)2.Cl2] respectively in DMSO at 77 K. 
 
 
Fig. 8. X-ray diffraction pattern for [Ni(H2L3)Cl2]H2O. 
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splitting. However, the EPR parameters were found to 
satisfy the octahedral geometry. The giso value = 1.9537 
support the monomeric nature of the complex (Wood et 
al., 1996; Pilbrow, 1990).  The g|| = 2.5138 while g⊥ = 
1.9537,  which  is of characteristic of octahedral 
geometry.  
Table 4. Powder X-ray data of [Ni(H2L3)Cl2]H2O. 
 
Peak 2θ° dobs (Å) IntensityCount Intensity % (1/d2) (1/d2)/Z h    k    l 
1 7.776 11.3607 147 90.3 0.00775 1 1     0     0 
2 13.662 6.47613 104 63.7 0.02384 3 1     1     1 
3 15.477 5.72079 117 72.3 0.03056 4 2     0     0 
4 19.377 4.57718 88 54.2 0.04773 6 2     1     1 
5 20.521 4.32457 100 61.8 0.05327 8 2     2     0 
6 25.765 3.45499 156 96.1 0.08377 11 3     1     1 
7 26.469 3.36471 160 98.4 0.08833 11 3     1     1 
8 27.493 3.24158 163 100 0.09517 12 2     2     2 
9 29.124 3.06367 99.2 61 0.1065 14 3     2     1 
10 31.195 2.8649 91.9 56.6 0.1218 16 4     0     0 
11 48.765 1.86593 70.6 43.4 0.08255 10 3     1     0 
12 71.96 1.31114 55.9 34.4 0.5817 75 2     2     0 
13 77.556 1.22992 52.5 32.3 0.661 85 3     0     0 
14 84.784 1.14254 50.6 31.1 0.7661 99 3     1     0 
  
 
 
(a). [Pt(H2L3)2.Cl]  (b). [Mn(H2L3)(CH3COO)2] 
 
(c). [Zn(H2L3)(CH3COO)2H2O]  (d). [Ni(H2L3)Cl2]H2O 
 
(e). [Mo(H2L3)Cl3]
 
Fig. 9. Proposed structures of (a): [Pt(H2L3)2.Cl], (b): [Mn(H2L3)(CH3COO)2], (c): [Zn(H2L3)(CH3COO)2H2O], 
(d): [Ni(H2L3)Cl2]H2O  and (e): [Mo(H2L3)Cl3] 
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Powder X-ray diffraction study 
X-ray powder diffraction pattern for Ni(II) complex 
recorded on a Bruker AXS D8 Advance diffractometer 
operating in the θ:θ mode, equipped with a secondary 
beam graphite monochromator is as shown in (Fig. 8). 
The diffractogram of Ni(II) complex consists of fourteen 
reflections in the range of 7.776-84.784 (2θ value) with 
maxima at 2θ = 9.294 Å. The major peaks of relative 
intensity greater than 10% were indexed using a computer 
programme (Table 4) (Nomiya et al., 2004; Lipson, 
1949). This indexing method also yields the Miller 
indices (hkl), the unit cell parameters and the unit cell 
volume. The unit cell of Ni(II) complex yielded values of 
lattice constants: a = 12.868 Å and c = 22.154 Å, and a 
unit cell volume V = 3176.909 Å3 which is in consistence 
with trigonal parameters. The conditions satisfied trigonal 
samples with conditions such as a = b ≠ c and α = β = 90˚; 
γ = 120˚. Hence, it can be concluded [Ni(H2L3)Cl2]H2O 
complexes was trigonal bipyramidal crystal systems.  
 
Based on the analytical and spectroscopic data obtained, 
the modeling structures for the metal complexes of H2L3 
synthesized are shown in figure 9: 
 
Antimycobacterial study  
The antitubercular efficacy of the hydrazone and the 
metal complexes except that of Mo(V) complex were 
determined by screening them against Mycobacterium 
tuberculosis H37Rv. (ATCC 35837). Minimum inhibitory 
concentrations (MIC) were determined by microbroth 
dilution in accordance with the methods of the National 
Committee for Clinical Laboratory Standards (NCCLS) as 
described earlier (Anna et al., 2009; Koen Andries et al., 
2005) and MIC’s are given in Table 5. Standard drugs, 
isoniazid was used as positive control while DMSO was 
used as solvent.  
 
Table 5. MIC (µg/mL), IC50 (µM) and SI (IC50/MIC) values of the metal complexes of H2L3. 
 
Entry Compound MIC (µg/mL) IC50 (µM) SI (IC50/MIC) 
H2L3 
 
0.82 ± 0.016 2.25 2.74 
PtL3 
 
0.88  ± 0.033 2.19 2.19 
MnL3 
 
0.78  ± 0.062 0.92 1.30 
NiL3 
 
1.19  ± 0.194 1.21 1.83 
ZnL3 
 
0.62  ± 0.031 1.34 1.34 
INH - 0.91 ± 0.133 - - 
 
 
* > 0.05   ** > 0.05 
 
Fig. 10. Comparing MIC (µg/mL) values of the metal complexes of H2L3 with the ligand (H3L2) and isoniazid (INH) 
drug. 
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The MIC results for the ligand, H2L3 (Table 5; Fig. 10) 
was compared to four of its transition metal complexes. 
The MIC’s result illustrates that H2L3 exhibited promising 
anti-tubercular activity with MIC value of 0.82 µg/mL 
compared to isoniazid (0.91 µg/mL). Also, metal 
complexes with coordinated methoxyl group (MnL3 and 
ZnL3) showed higher activity than isoniazid with MIC 
value of 0.78 and 0.62 µg/mL respectively. The two 
complexes exhibited anti-tubercular potency than the 
standard drug. The potency of the compounds observed 
could be attributed to coordination ligand to metal ion, as 
well as the presence of OCH3 substituent in the molecule 
of the complexes. However, PtL3 complex (0.88 µg/mL) 
with one coordinated chlorine atom was found to be more 
active than complex NiL3 complex (1.19 µg/mL) with 
two coordinated chlorine atoms. Thus, NiL3 complex was 
found with reduction in inhibition potential. Generally, 
the results indicate that MnL3 and ZnL3 are more potent 
than the hydrazone and Isoniazid with low toxicity. This 
observation was supported with the test of signicant 
which indicated that P0.05 for all the complexes. 
However, PtL3 was found with highest toxicity with IC50 
value of 1.93 µM.  
 
CONCLUSION 
 
In conclusion, an acylhydrazone was successfully 
synthesized from nicotinic hydrazide by cold 
condensation reaction. The hydrazone formation was 
confirmed by one and two dimentional NMR techniques. 
The novel metal complexes of the hydrazone were 
successfully synthesized. The structures of the metal 
complexes were elucidated on the basis of analytical data, 
ESR, magnetic measurement, DTA/TGA and powder X-
ray study. All the efforts made to grow single crystals of 
the metal complexes did not yield positive results. The 
anti-tubercular efficacies of the compounds were 
established. The hydrazone (H2L3) and some of the metal 
complexes (MnL3, ZnL3 and PtL3) were found to possess 
better activity as compared to isoniazid. 
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